Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.38 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | F13A1 | P00488 | 3/20 | 0.35 |
| ▸ | LTB4R | Q15722 | 3/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.32 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.32 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.32 |
| ▸ | CCR2 | P41597 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30428061 | 0.80 | F13A1 (0.51) | HDAC1HDAC8F13A1LTB4RLMNA | |
| SCHEMBL19194935 | 0.78 | LTB4R2 (0.41) | HDAC1HDAC8TBXAS1ALDH1A1LTB4R | |
| SCHEMBL19194942 | 0.78 | LTB4R (0.36) | HDAC1HDAC8TBXAS1ALDH1A1F13A1 | |
| SCHEMBL29010120 | 0.75 | F13A1 (0.44) | HDAC1HDAC8F13A1 | |
| SCHEMBL22748776 | 0.75 | ALOX5 (0.43) | HDAC1HDAC8ALOX5HTT | |
| SCHEMBL17525546 | 0.75 | ROCK1 (0.38) | HDAC1HDAC8TBXAS1LTB4RLTB4R2 | |
| SCHEMBL7647324 | 0.73 | ALOX5 (0.41) | HDAC1HDAC8ALOX5HTT | |
| SCHEMBL15632913 | 0.72 | FFAR1 (0.46) | — | |
| SCHEMBL17525545 | 0.71 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL3659997 | 0.71 | CA2 (0.39) | ALDH1A1ALOX5CCR2NPC1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170222226-A1 | REDOX MEDIATORS FOR METAL-SULFUR BATTERIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2017-08-03 | — | — | US | disclosed |
| US-20170222226-A1 | REDOX MEDIATORS FOR METAL-SULFUR BATTERIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2017-08-03 | — | — | US | disclosed |
| WO-2016025467-A1 | REDOX MEDIATORS FOR METAL-SULFUR BATTERIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170222226-A1 | REDOX MEDIATORS FOR METAL-SULFUR BATTERIES | SQOR, NDUFS4, NDUFS3 | HDAC1 2317/4885HDAC8 4269/4885TBXAS1 1276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.